Increased Lymphangiogenesis and Lymphangiogenic Growth Factor Expression in Perivascular Adipose Tissue of Patients with Coronary Artery Disease
暂无分享,去创建一个
C. Vahl | T. Münzel | D. Tziakas | G. Chalikias | M. Pavlaki | S. Konstantinides | D. Mikroulis | K. Buschmann | K. Schäfer | F. Konstantinou | Magdalena L. Bochenek | I. Drosos | Christos Tortopidis | R. Gogiraju | Maria Del Pilar Ortega Carrillo | A. Kourkouli
[1] Marenao Tanaka,et al. Differential Phenotypes in Perivascular Adipose Tissue Surrounding the Internal Thoracic Artery and Diseased Coronary Artery , 2019, Journal of the American Heart Association.
[2] Takayuki Katsuno,et al. Roles of the TGF-β–VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis , 2018, International journal of molecular sciences.
[3] G. Santulli. The lymphatic border patrol outwits inflammatory cells in myocardial infarction , 2018, Science Translational Medicine.
[4] D. Greaves,et al. The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction , 2018, The Journal of clinical investigation.
[5] W. Kilarski. Physiological Perspective on Therapies of Lymphatic Vessels , 2018, Advances in wound care.
[6] M. Sata,et al. Roles of Perivascular Adipose Tissue in the Pathogenesis of Atherosclerosis , 2018, Front. Physiol..
[7] P. Xia,et al. Gene expression profiling reveals heterogeneity of perivascular adipose tissues surrounding coronary and internal thoracic arteries , 2017, Acta biochimica et biophysica Sinica.
[8] R. Goldschmeding,et al. Connective tissue growth factor regulates fibrosis-associated renal lymphangiogenesis. , 2017, Kidney international.
[9] M. Detmar,et al. An Important Role of VEGF-C in Promoting Lymphedema Development. , 2017, The Journal of investigative dermatology.
[10] S. Konstantinides,et al. Perivascular adipose tissue: epiphenomenon or local risk factor? , 2017, International Journal of Obesity.
[11] K. Alitalo,et al. Adventitial lymphatic capillary expansion impacts on plaque T cell accumulation in atherosclerosis , 2017, Scientific Reports.
[12] H. Augustin,et al. Angiopoietin‐2 mediates thrombin‐induced monocyte adhesion and endothelial permeability , 2016, Journal of thrombosis and haemostasis : JTH.
[13] T. Münzel,et al. Differences between perivascular adipose tissue surrounding the heart and the internal mammary artery: possible role for the leptin-inflammation-fibrosis-hypoxia axis , 2016, Clinical Research in Cardiology.
[14] G. Mayer,et al. Effects of LDL Receptor Modulation on Lymphatic Function , 2016, Scientific Reports.
[15] Y. Reiss,et al. Angiopoietin‐2: a multifaceted cytokine that functions in both angiogenesis and inflammation , 2015, Annals of the New York Academy of Sciences.
[16] Qian Chen,et al. Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model. , 2015, Journal of atherosclerosis and thrombosis.
[17] J. Esko,et al. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development , 2015, Nature Communications.
[18] GrzegorekIrmina,et al. Arterial Wall Lymphangiogenesis Is Increased in the Human Iliac Atherosclerotic Arteries: Involvement of CCR7 Receptor , 2014 .
[19] K. Alitalo,et al. Blockade of VEGF-C and VEGF-D modulates adipose tissue inflammation and improves metabolic parameters under high-fat diet , 2014, Molecular metabolism.
[20] Walter L Murfee,et al. VEGF‐C Induces Lymphangiogenesis and Angiogenesis in the Rat Mesentery Culture Model , 2014, Microcirculation.
[21] Sila Appak,et al. Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions , 2014, Genes & development.
[22] T. Petrova,et al. Pressing the right buttons: signaling in lymphangiogenesis. , 2014, Blood.
[23] P. Carmeliet,et al. Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1α-independent translation-mediated mechanism. , 2014, Cell reports.
[24] Renu Virmani,et al. Why is the mammary artery so special and what protects it from atherosclerosis? , 2013, Annals of cardiothoracic surgery.
[25] K. Golba,et al. Mechanisms of vasodilatatory effect of perivascular tissue of human internal thoracic artery. , 2013, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[26] Kim Pin Yeo,et al. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. , 2013, Cell metabolism.
[27] Robert Bittman,et al. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. , 2013, The Journal of clinical investigation.
[28] A. Szuba,et al. Adventitial lymphatics and atherosclerosis. , 2012, Lymphology.
[29] S. Ylä-Herttuala,et al. Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol‐rich and calcified atherosclerotic lesions , 2011, European journal of clinical investigation.
[30] Y. Tabata,et al. Augmented angiogenesis in adventitia promotes growth of atherosclerotic plaque in apolipoprotein E-deficient mice. , 2011, Atherosclerosis.
[31] Jean-Baptiste Michel,et al. Intraplaque haemorrhages as the trigger of plaque vulnerability , 2011, European heart journal.
[32] S. Stone-Elander,et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake , 2010, Nature.
[33] D. Zawieja,et al. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. , 2010, Blood.
[34] Sai T Reddy,et al. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. , 2009, The American journal of pathology.
[35] M. Skobe,et al. Inflamed Lymphatic Endothelium Suppresses Dendritic Cell Maturation and Function via Mac-1/ICAM-1-Dependent Mechanism1 , 2009, The Journal of Immunology.
[36] Renu Virmani,et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. , 2009, Journal of the American College of Cardiology.
[37] K. Becker,et al. VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis , 2009, Proceedings of the National Academy of Sciences.
[38] A. Szuba,et al. Adventitial lymphatics of internal carotid artery in healthy and atherosclerotic vessels. , 2009, Folia histochemica et cytobiologica.
[39] H. Wolburg,et al. Development of the Zebrafish Lymphatic System Requires Vegfc Signaling , 2006, Current Biology.
[40] H. Augustin,et al. Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.
[41] Y. Yonemitsu,et al. Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. , 2005, Human pathology.
[42] David Zurakowski,et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[43] S. Hirakawa,et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.
[44] K. Alitalo,et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. , 2002, The American journal of pathology.
[45] P. Campochiaro,et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. , 2002, Developmental cell.
[46] M. Siemionow,et al. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. , 2002, Blood.
[47] M. Detmar,et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype , 2002, The EMBO journal.
[48] D. Kerjaschki,et al. Isolation and Characterization of Dermal Lymphatic and Blood Endothelial Cells Reveal Stable and Functionally Specialized Cell Lineages , 2001, The Journal of experimental medicine.
[49] K. Alitalo,et al. Adenoviral Expression of Vascular Endothelial Growth Factor-C Induces Lymphangiogenesis in the Skin , 2001, Circulation research.
[50] M. Saito,et al. Isoform-specific regulation of vascular endothelial growth factor (VEGF) family mRNA expression in cultured mouse brown adipocytes , 2001, Molecular and Cellular Endocrinology.
[51] T. Veikkola,et al. Signalling via vascular endothelial growth factor receptor‐3 is sufficient for lymphangiogenesis in transgenic mice , 2001, The EMBO journal.
[52] J. Ward,et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. , 2000, Blood.
[53] A. Albini,et al. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[54] G. Yancopoulos,et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.
[55] K. Alitalo,et al. Vascular endothelial growth factor C induces angiogenesis in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Isner,et al. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. , 1998, The American journal of pathology.
[57] K. Alitalo,et al. Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen Vascular Endothelial Growth Factor-C* , 1998, The Journal of Biological Chemistry.
[58] K. Alitalo,et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[59] R. Jain,et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. , 1997, Science.
[60] F. H. Sims,et al. A comparison of coronary and internal mammary arteries and implications of the results in the etiology of arteriosclerosis. , 1983, American heart journal.
[61] G. Hoggan,et al. The Lymphatics of the Walls of the Larger Blood-Vessels and Lymphatics. , 1882, Journal of anatomy and physiology.
[62] A. Szuba,et al. Arterial Wall Lymphangiogenesis Is Increased in the Human Iliac Atherosclerotic Arteries : Involvement of CCR 7 Receptor , 2014 .
[63] A. Shah,et al. Leptin promotes the mobilization of vascular progenitor cells and neovascularization by NOX2-mediated activation of MMP9. , 2012, Cardiovascular research.
[64] Ningfei Liu,et al. Angiopoietin-2 promotes inflammatory lymphangiogenesis and its effect can be blocked by the specific inhibitor L1-10. , 2012, American journal of physiology. Heart and circulatory physiology.
[65] A. Naylor,et al. Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. , 2007, Journal of vascular surgery.
[66] J. Partanen,et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins , 2004, Nature Immunology.
[67] K. Alitalo,et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. , 1996, The EMBO journal.